The present invention, which is applicable in the pharmaceutical industry,relates to the use of fibrates, in particularfenofibrate, especially in the form of a solid oral composition, for themanufacture of a drug for the treatment of sleep apnea,sleep apnea syndrome, in particular obstructive sleep apnea or obstructivesleep apnea syndrome.